Position in IDYA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,629,613
+$420,109 QoQ
Shares Held
228,980
+9.8% QoQ
Ownership
0.261%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Derivatives in IDYA
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$4,224,976
PutShares
126,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. IDYA ranks #137 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in IDYA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,629,613 | 228,980 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $4,224,976 | 126,800 | Put | Sole | 2026-05-15 | |
| 2025-12-31 | $7,209,504 | 208,548 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,743,687 | 137,585 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,401,739 | 66,686 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $8,970,294 | 547,637 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,161,408 | 123,012 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,837,126 | 342,081 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,079,656 | 258,606 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,064,698 | 138,211 | Shares | Sole | 2024-05-15 | |
| 2023-03-31 | $236,183 | 17,202 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,387,378 | 186,427 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $1,379,751 | 99,982 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,409,626 | 125,972 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $548,518 | 23,203 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $266,676 | 10,462 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,590,103 | 123,397 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $427,700 | 18,200 | Put | Sole | 2021-05-17 | |
| 2021-03-31 | $2,780,332 | 118,312 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,200,346 | 85,739 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,253,864 | 99,830 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,246,785 | 87,740 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $244,167 | 59,264 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||